权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Studies of Substituted Amphetamine Neurotoxicity

替代安非他明神经毒性的研究

基本信息

批准号：
7599584
负责人：
GEORGE A RICAURTE
金额：
$ 12.89万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-04-15 至 2011-03-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): This revised application for a Senior Scientist Award (K05) is submitted to enable the applicant to continue engaging in drug abuse research for the next five years. Research in the applicant's laboratory focuses on substituted amphetamine derivatives (MDMA, methamphetamine) and their propensity to selectively damage brain serotonin and/or dopamine neurons in animals and, possibly, humans. The long-term goals of this research are to better define risks and consequences of substituted amphetamine exposure in humans, and to further elucidate the role of serotonin and dopamine in the central nervous system (CNS), both in health and disease. In addition, this research seeks to identify the mechanism by which substituted amphetamines damage brain aminergic neurons, as this information may yield insight into the processes underlying neuronal loss in human neurodegenerative conditions. A variety of methods are used to achieve these goals. Studies in isolated systems (gene microarrays, synaptosomes and cultured cells) and intact animals (rodents) explore mechanisms of substituted amphetamine neurotoxicity, identify critical molecular requirements for the expression of neurotoxicity, and characterize the short- and long-term responses of serotonin and dopamine neurons to substituted amphetamine neurotoxicity. Studies in nonhuman primates seek to more accurately gauge the risk that substituted amphetamines pose to humans and to develop and validate methods for detecting the consequences of substituted amphetamine neurotoxicity in humans. Studies in humans, which include molecular PET imaging, pharmacologic challenges, neuropsychiatric evaluations, cognitive testing and polysomnographic evaluations, are designed to determine whether humans who use substituted amphetamines develop neurotoxicity and, if so, the functional consequences. By decreasing the amount of time required for clinical work, teaching, administration and other departmental duties, this K05 award will enable the applicant to optimize research productivity, continue training junior faculty and fellows in his laboratory, and participate in national and international forums intended to educate the public regarding the neurotoxic potential of substituted amphetamines.

描述（由申请人提供）：提交高级科学家奖（K 05）的修订申请，使申请人能够在未来五年内继续从事药物滥用研究。申请人实验室的研究重点是取代的安非他明衍生物（MDMA，甲基安非他明）及其选择性损害动物（可能包括人类）大脑5-羟色胺和/或多巴胺神经元的倾向。这项研究的长期目标是更好地确定人类接触替代安非他明的风险和后果，并进一步阐明5-羟色胺和多巴胺在中枢神经系统（CNS）中的作用，包括健康和疾病。此外，本研究旨在确定取代安非他明损害脑胺能神经元的机制，因为这些信息可能会深入了解人类神经退行性疾病中神经元丢失的过程。为实现这些目标，采用了各种方法。在隔离系统（基因微阵列、突触体和培养细胞）和完整动物（啮齿动物）中进行的研究探索了取代苯丙胺神经毒性的机制，确定了神经毒性表达的关键分子要求，并描述了5-羟色胺和多巴胺神经元对取代苯丙胺神经毒性的短期和长期反应。在非人类灵长类动物中进行的研究旨在更准确地衡量替代安非他明对人类造成的风险，并开发和验证检测替代安非他明对人类神经毒性后果的方法。人体研究，包括分子PET成像，药理学挑战，神经精神评价，认知测试和多导睡眠图评价，旨在确定使用替代安非他明的人是否会产生神经毒性，如果是，功能后果。通过减少临床工作，教学，行政和其他部门职责所需的时间，该K 05奖将使申请人能够优化研究生产力，继续在他的实验室培训初级教师和研究员，并参加旨在教育公众的国家和国际论坛关于替代安非他明的神经毒性潜力。